Neuraminidase inhibitors: who, when, where?
Open Access
- 1 March 2015
- journal article
- review article
- Published by Elsevier in Clinical Microbiology and Infection
- Vol. 21 (3) , 222-225
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Oseltamivir treatment for influenza in adults: a meta-analysis of randomised controlled trialsThe Lancet, 2015
- Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant dataThe Lancet Respiratory Medicine, 2014
- Influenza Infection Screening Tools Fail to Accurately Predict Influenza Status for Hospitalized Patients During Pandemic H1N1 Influenza SeasonCanadian Respiratory Journal, 2013
- Impact of Neuraminidase Inhibitor Treatment on Outcomes of Public Health Importance During the 2009-2010 Influenza A(H1N1) Pandemic: A Systematic Review and Meta-Analysis in Hospitalized PatientsThe Journal of Infectious Diseases, 2012
- Diagnosing swine flu: the inaccuracy of case definitions during the 2009 pandemic, an attempt at refinement, and the implications for future planningInfluenza and Other Respiratory Viruses, 2012
- Meta-analysis of individual participant data: rationale, conduct, and reportingBMJ, 2010
- Accuracy of Clinical Diagnosis of Influenza in Outpatient ChildrenClinical Infectious Diseases, 2005
- Impact of Oseltamivir Treatment on Influenza-Related Lower Respiratory Tract Complications and HospitalizationsArchives of internal medicine (1960), 2003
- Common Emergence of Amantadine‐ and Rimantadine‐Resistant Influenza A Viruses in Symptomatic Immunocompromised AdultsClinical Infectious Diseases, 1998
- Emergence and Possible Transmission of Amantadine-resistant Viruses during Nursing Home Outbreaks of Influenza A (H3N2)American Journal of Epidemiology, 1991